Posted in | News | LEDs | Lighting | Medical Optics

Divestiture of Surgical Lighting, Solarc Product Lines by Welch Allyn

Welch Allyn, a leading manufacturer of frontline medical products and solutions, today announced it has divested its surgical lighting and specialty metal halide (Sôlarc®) product lines. According to President and CEO Julie Shimer, the move is a key step in the company’s strategy to exit the surgical headlight and non-medical lighting portion of its business in order to fully focus on diagnostic medical devices, service and solutions for its customers.

Welch Allyn plans to work aggressively over the transition period to minimize any impact on employees, and feels if business conditions remain stable most, if not all employees, will be retained and redeployed into the company.

“Several years ago, as part of our overall Strategic Direction, Welch Allyn made the decision to gradually exit the parts of our business that were not directly related to our core medical focus areas, and the divestiture of these product lines is a key step in this process,” said Shimer. “Welch Allyn was founded more than 90 years ago by introducing the world’s first hand-held direct-illuminating ophthalmoscope, and we intend to remain true to the legacy of delivering quality medical devices which are the core of our company’s growth and success. By redeploying our people and assets we continue to put even greater innovation into the hands of frontline caregivers and their patients around the world. We are committed to focusing on what we do best—developing and manufacturing innovative, high-quality medical devices.”

Welch Allyn will continue to grow the medical office lighting portion of the business and LED-based medical lights, including the recently introduced Green Series Medical Exam Lights. In addition, the manufacture of Welch Allyn precision OEM specialty halogen lighting products will remain fully operational with no interruption in sales, service or support.

Ushio America, Inc. based in Cypress, CA, a leading manufacturer of Specialty and General Illumination lighting solutions, has purchased the Welch Allyn Sôlarc specialty metal halide product line of lighting products.

In addition, New Jersey-based Integra LifeSciences Corporation has purchased all Welch Allyn surgical headlight assets, which includes the ProXenon and CL lines of surgical headlight products and accessories. Integra is a leading medical device company focusing on regenerative medicine and innovation of cost-effective surgical implants and medical instruments for neurosurgery, orthopedics and general surgery.

A three- to 12-month transition period is expected, during which most of the existing Welch Allyn lighting products workforce will be redeployed within the company into jobs matching individual skill sets. Based on current business conditions, the company expects that few employees will be impacted by the end of the transition period but will offer comprehensive severance packages and the resources of a nationally-based employment service to those who may experience a job loss.



Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    USHIO America, Inc.. (2019, March 01). Divestiture of Surgical Lighting, Solarc Product Lines by Welch Allyn. AZoOptics. Retrieved on April 23, 2024 from

  • MLA

    USHIO America, Inc.. "Divestiture of Surgical Lighting, Solarc Product Lines by Welch Allyn". AZoOptics. 23 April 2024. <>.

  • Chicago

    USHIO America, Inc.. "Divestiture of Surgical Lighting, Solarc Product Lines by Welch Allyn". AZoOptics. (accessed April 23, 2024).

  • Harvard

    USHIO America, Inc.. 2019. Divestiture of Surgical Lighting, Solarc Product Lines by Welch Allyn. AZoOptics, viewed 23 April 2024,

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.